News
Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...
Eli Lilly on Thursday reported promising results for a daily pill that could serve as an alternative to injectable ...
2d
24/7 Wall St. on MSNThese 2 Dividend Giants Are at 52-Week Lows. Time to Buy?One man's trash may be another man's treasure, but dumpster diving when investing carries risks. You have to wade through a ...
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
PARIS – Amid the luxury slowdown, Hermès International showed continued strength with sales in the first quarter up 7 percent ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and ...
Pfizer on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient experienced potential drug-induced liver injury which resolved after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results